Ventyx Biosciences Overview

  • Founded
  • 2018
Founded
  • Status
  • Public
  • Employees
  • 23
Employees
  • Stock Symbol
  • VTYX
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $13.13
  • (As of Monday Closing)

Ventyx Biosciences General Information

Description

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Contact Information

Website
www.ventyxbio.com
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 662 Encinitas Boulevard
  • Suite 250
  • Encinitas, CA 92024
  • United States
+1 (858) 000-0000

Ventyx Biosciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ventyx Biosciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.13 $13.51 $9.50 - $26.00 $680M 50.3M 157K -$16.82

Ventyx Biosciences Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 0 0 0
EBITDA (82,414) (27,816) (4,181)
Net Income (82,680) (28,174) (4,327)
Total Assets 148,709 245 349
Total Debt 0 12,647 3,846
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ventyx Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ventyx Biosciences‘s full profile, request access.

Request a free trial

Ventyx Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Ventyx Biosciences‘s full profile, request access.

Request a free trial

Ventyx Biosciences Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Ventyx Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210139486-A1 Tyk2 pseudokinase ligands Pending 08-Nov-2019 0000000000
AU-2020247990-A1 Tyk2 pseudokinase ligands Pending 26-Mar-2019 0000000000
CA-3134814-A1 Tyk2 pseudokinase ligands Pending 26-Mar-2019 0000000000
AU-2020218267-A1 Tyk2 pseudokinase ligands Pending 07-Feb-2019 0000000000
CA-3129438-A1 Tyk2 pseudokinase ligands Pending 07-Feb-2019 C07D487/04
To view Ventyx Biosciences’s complete patent history, request access »

Ventyx Biosciences Executive Team (6)

Name Title Board Seat Contact Info
Martin Auster MD Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Jorn Drappa Ph.D Co-Chief Medical Officer
Richard Gregg MD Co-Chief Medical Officer
Raju Mohan Ph.D Chief Executive Officer & Board Member
John Nuss Ph.D Chief Scientific Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Ventyx Biosciences Board Members (7)

Name Representing Role Since
Aaron Royston MD venBio Board Member 000 0000
Jigar Choksey Third Point Ventures Board Member 000 0000
Raju Mohan Ph.D Self Chief Executive Officer & Board Member 000 0000
Richard Gaster Ph.D venBio Board Member 000 0000
Sheila Gujrathi MD Ventyx Biosciences Chairman & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Ventyx Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ventyx Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ventyx Biosciences‘s full profile, request access.

Request a free trial

Ventyx Biosciences Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 09-Mar-2021 0000000000 Biotechnology
Oppilan Pharma 01-Feb-2021 Merger/Acquisition 00000 Drug Discovery 0000 0000
To view Ventyx Biosciences’s complete acquisitions history, request access »